NASDAQ:DCBO • CA25609L1058
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for DOCEBO INC (DCBO).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-02 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2026-03-02 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-27 | Needham | Maintains | Buy -> Buy |
| 2026-01-30 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2026-01-29 | Needham | Reiterate | Buy -> Buy |
| 2026-01-21 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-11-10 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-11-07 | Needham | Maintains | Buy -> Buy |
| 2025-11-05 | Oppenheimer | Initiate | Outperform |
| 2025-10-29 | CIBC | Maintains | Outperformer -> Outperformer |
| 2025-10-03 | TD Cowen | Reiterate | Buy |
| 2025-10-03 | TD Securities | Reiterate | Buy |
| 2025-06-09 | Cantor Fitzgerald | Initiate | Overweight |
| 2025-05-12 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-05-12 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2025-04-16 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-04-10 | Needham | Reiterate | Buy -> Buy |
| 2025-03-04 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2024-11-11 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-11-08 | Needham | Maintains | Buy -> Buy |
| 2024-10-24 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2024-09-12 | Needham | Maintains | Buy -> Buy |
| 2024-06-21 | CIBC | Maintains | Outperformer -> Outperformer |
| 2024-06-12 | Needham | Reiterate | Buy -> Buy |
| 2024-06-07 | Craig-Hallum | Initiate | Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 180.839M 26.54% | 216.931M 19.96% | 242.687M 11.87% | 273.98M 12.89% | 305.32M 11.44% | 342.82M 12.28% | 671.16M 95.78% | 813.96M 21.28% | 975.12M 19.80% | N/A | N/A | |
| EBITDA YoY % growth | 3.821M 183.17% | 22.291M 483.38% | 27.665M 24.11% | 54.831M 98.20% | 67.022M 22.23% | 75.48M 12.62% | 74.97M -0.68% | 83.436M 11.29% | 96.288M 15.40% | 105.57M 9.64% | 120.36M 14.01% | |
| EBIT YoY % growth | 680K 109.82% | 18.907M 2,680.44% | 24.479M 29.47% | 41.541M 69.70% | 54.786M 31.88% | 66.912M 22.13% | 142.8M 113.41% | 185.64M 30.00% | N/A | N/A | N/A | |
| Operating Margin | 0.38% | 8.72% | 10.09% | 15.16% | 17.94% | 19.52% | 21.28% | 22.81% | N/A | N/A | N/A | |
| EPS YoY % growth | 0.09 -55.00% | 0.86 855.56% | 1.35 56.98% | 1.61 18.91% | 1.91 18.92% | 2.39 25.04% | 2.93 22.65% | 3.69 26.13% | N/A | N/A | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.33 23.41% | 0.38 31.02% | 0.43 27.50% | 0.48 6.53% | 0.35 4.08% | 0.39 2.01% | 0.40 -8.24% | 0.43 -10.64% |
| Revenue Q2Q % growth | 64.967M 13.39% | 67.762M 11.58% | 69.519M 12.82% | 71.706M 13.75% | 72.203M 11.14% | 74.862M 10.48% | 77.519M 11.51% | 80.002M 11.57% |
| EBITDA Q2Q % growth | 10.656M 62.27% | 12.611M 75.40% | 15.166M 36.82% | 16.092M 27.63% | 14.844M 39.30% | 15.185M 20.41% | 18.081M 19.22% | 19.323M 20.08% |
| EBIT Q2Q % growth | 7.611M 31.93% | 9.982M 80.02% | 12.74M 46.49% | 13.406M 42.28% | 11.189M 47.01% | 11.512M 15.33% | 14.563M 14.31% | 15.336M 14.40% |
All data in USD
16 analysts have analysed DCBO and the average price target is 25.57 USD. This implies a price increase of 73.92% is expected in the next year compared to the current price of 14.7.
DOCEBO INC (DCBO) will report earnings on 2026-05-07.
The consensus EPS estimate for the next earnings of DOCEBO INC (DCBO) is 0.33 USD and the consensus revenue estimate is 64.97M USD.
The expected long term growth rate for DOCEBO INC (DCBO) is 11.56%.